Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Grant supports the expansion of their rapid, high-resolution LinkPrep™ technology in transforming cancer research SCOTTS VALLEY, Calif., Nov. 6, 2024 /PRNewswire/ -- Dovetail Genomics, a leading...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Sterling Infrastructure, Inc. (NasdaqGS: STRL) ("Sterling" or "the Company") today announced that management is participating in the following investor conferences: Baird Global Industrial...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Positive End of Phase 2 discussion with FDA, including alignment on Phase 3 design Bayley-4 expressive communication selected as Phase 3 study primary endpoint Initiation of ION582 Phase 3 study...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to personalized medicine and cell therapy...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Treatment with TPN-101 showed clinical benefits on key clinical outcome measures, including the Revised ALS Functional Rating Scale (ALSFRS-R) and Slow Vital Capacity (SVC) TPN-101 also had...